Devyser wins tender in Italy worth approximately SEK 5.7 million – doubling test volumes compared with previous agreement
Devyser Diagnostics AB, through its Italian subsidiary, has been awarded a renewed tender by...
Simple, fast, accurate genetic testing solutions
Are you a pioneer pushing brave new frontiers in genetic testing? Together we can make personalized healthcare available to all. Our DNA test kits are fast, accurate, and easy to use – for the smoothest lab workflows. Join our journey!
Post-transplantation monitoring
Screening for early detection of graft rejection and minimal residual disease in bone marrow and stem cell transplant patients. Learn more
Hematology
Tests to evaluate multiple blood conditions and guide personalized treatment and family planning. Learn more
Cardiovascular diseases
Fast diagnosis and cascade screening for monogenic and polygenic familial hypercholesterolemia. Learn more
News | June 26, 2025
Devyser launches Devyser HLA Loss: A high-precision NGS assay for post-transplant researchNews | October 29, 2024
Devyser seeks to secure FDA approval for NGS test for kidney transplant monitoringNews | October 28, 2024
Devyser Compact achieves Class III approval in China
Devyser extends its transplant test to heart and lung patients
Devyser announced that One Lambda™ Devyser Accept cfDNA, its test for monitoring kidney transplant...
Relapse after allogeneic stem cell transplantation: Is it time for routine HLA loss testing?
Allogeneic hematopoietic stem cell transplantation (allo-HCT) remains one of the few potentially...
Same disease, different testing approaches: global survey highlights the need for standardized FH genetic testing
Familial hypercholesterolemia (FH) is a common inherited disorder affecting approximately 1 in 250...